International Flavors & Fragrances Health & Biosciences — Cost of Sales increased by 3.8% to $327.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from $298.00M to $327.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to sales may indicate rising input costs or manufacturing inefficiencies.
The direct costs attributable to the production of goods and services sold by the Health & Biosciences segment. This inc...
Standard 'Cost of Goods Sold' (COGS) metric used across manufacturing and chemical industries.
iff_segment_health_biosciences_cost_of_sales| Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|
| Value | $286.00M | $294.00M | $305.00M | $298.00M | $311.00M | $315.00M | $327.00M |
| QoQ Change | — | +2.8% | +3.7% | -2.3% | +4.4% | +1.3% | +3.8% |
| YoY Change | — | — | — | +4.2% | +5.8% | +3.3% | +9.7% |